DOLBY LABORATORIES, INC. (DLB): what the price assumes
In the published model solve dated 2026-Q2, anchored at $61.50, DOLBY LABORATORIES, INC. (DLB) is priced for +15.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.
Generated: 2026-08-30 · Source: https://boothcheck.com/report/DLB
Headline
| Field | Value |
|---|---|
| Ticker | DLB |
| Company | DOLBY LABORATORIES, INC. |
| Sector / Industry | Technology |
| Current price | $61.50/sh |
| Composition | Licensing 93% / Products and services 7% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Implied growth | 15.0% |
| Multiple paid | 20x operating income |
Solve inputs: computed at a 9% cost of capital with 4% terminal growth over a 5-year stage.
How unusual the bet is: within-range (limited comparison data)
| Reference | Value |
|---|---|
| vs own history | +0.66σ |
| cohort percentile (of 188 peers) | 28 |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 2.48x | 5 | expensive |
| Earnings | 2.10x | 4 | expensive |
| Relative | 1.62x | 3 | expensive |
| Growth | 1.17x | 3 | expensive |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.
Per-Model Detail (n=15)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $52.63 | 1.17x | yes | FCF base $0.4B, growth 0% (input: historical growth), terminal g 0.5%, WACC 9.1%, 5yr projection |
| DCF Exit Multiple | Growth | $61.02 | 1.01x | yes | Exit EV/EBITDA: 18.6x / 20.6x / 22.6x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $43.83 | 1.40x | yes | P/E 18x (static sector reference · 2026-04), scenarios: 15.3x / 18.0x / 20.7x (bear / base = reference held flat / bull), EV/EBITDA 14.58x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $25.51 | 2.41x | yes | BV/sh $26.95, ROE (TTM) 8.8%, ke 9.3% |
| Two-Stage Excess Return | Asset | $24.82 | 2.48x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $40.09 | 1.53x | yes | Rev $1.4B, growth 0% (input: historical growth; tapered), Terminal P/S: 3.7x / 4.4x / 5.0x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $24.16 | 2.55x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.25B × (1−33%) / WACC 9.1% → EPV (no growth) |
| Residual Income | Asset | $24.70 | 2.49x | yes | BV $26.95 + 5yr PV of (ROE (TTM) 8.8% − Kₑ 9.3%) × BV; BV grows 5.7%/yr |
| Graham Number | Asset | $37.67 | 1.63x | yes | √(22.5 × EPS $2.34 × BVPS $26.95) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $37.90 | 1.62x | yes | EBITDA $0.26B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $49.23 | 1.25x | yes | FCF $392.7M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $34.58 | 1.78x | yes | SBC-adj FCF $0.26B (FCF $0.39B − SBC $0.13B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $1.96 | 31.38x | yes | EPS $2.34 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $3.23 | 19.04x | yes | BV $26.95 × (ROIC 1.1% / WACC 9.1%) |
| P/Sales Sector | Relative | $35.32 | 1.74x | yes | Revenue $1.35B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $25.30 | 2.43x | yes | EPS $2.34 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Audio/video technology licensing & products (single reportable segment) | operating | enterprise | 1.3B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net cash | $670.0m |
| Net debt / NOPAT (after-tax) | -4.20x (net cash) |
| Net debt / operating income (pre-tax) | -2.80x (net cash) |
| Share count CAGR (buyback) | -1.8% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- Licensing is 93.0% of revenue, and the annual report states the clock under it without decoration: "Patents eventually expire", so the business has to keep replacing coverage it is losing.
- Revenue for the first half of fiscal 2026 rose about 2%, while operating profit went backwards to 175.1 million dollars from 187.6 million, because the expense base is growing faster than the royalty base.
- Fiscal third-quarter results are due on July 30, 2026, and they arrive against $594.7M in net cash with no borrowings drawn.
Bull Case
The market is pricing Dolby for a slow fade. At roughly 12 times company-wide operating income, today's price embeds operating profit shrinking about 0.9% a year for the next five years. That is the assumption a buyer inherits. What the most recent quarter actually reported was licensing revenue of $372.2 million for the three months to March 27, 2026, up 8% on the year.
The reason a licensing quarter like that matters more than it would at most companies is what it costs to produce. In fiscal 2025 the company booked $1,248.0 million of licensing revenue against $83.6 million of direct licensing cost. Once a codec is embedded in a chipset and a standard, the next television that ships carries a royalty and almost no incremental expense. The annual report frames the value exchange plainly, noting that "the advanced features of Dolby Atmos and Dolby Vision enhance the audio and video capabilities of our consumer electronics OEM partners' products", which is the whole commercial argument: the manufacturer pays because the feature sells the set.
Management is candid that a patent portfolio is a treadmill, and equally clear about how it stays on it: "We develop technologies to replace licensing revenue from technologies covered by expiring patents with licensing revenue supported by patents with a longer remaining life." That replacement engine has kept the licensing line growing, at 6% in fiscal 2025 and 8% in the March quarter. There is a second, less visible stream alongside it. The company recovers royalties on shipments that were never reported or were under-reported, and the filing describes these as "Recoveries are a recurring element of our business", which is an unusual thing to be able to say about compliance income.
Cost is where the near-term change is coming from. The company began restructuring in the second quarter of fiscal 2026 and expects it to produce about 20 million dollars of gross pre-tax savings in operating income this fiscal year, following actions in fiscal 2025 that produced roughly 20 million and 11 million dollars respectively. Research spending has already been held flat, at $261.8 million in fiscal 2025 against $263.7 million the year before, while licensing revenue grew. A royalty business that stops adding overhead converts almost all of its next revenue dollar into profit.
Capital comes back to holders without any financing risk attached. There are no funded borrowings, the company holds $594.7M in net cash, and the share count has fallen about 1.8% a year over the four years to March 27, 2026. The quarterly dividend was raised to $0.36 from $0.33, and $141.6 million of repurchase authorization was still available at the end of March.
Against the closest listed comparisons, the argument is that the gap is fixable rather than structural. IDCC earns a 49.6% operating margin on $828.9 million of revenue growing 1.6%, and RMBS earns 35.9% on $721.2 million growing 19.1%. Dolby's trailing operating margin of 23.2% is the lowest of the three, but the shortfall is not in gross economics, which are comparable. It sits in sales, marketing and administrative spending, which is the one line management directly controls.
Bear Case
Dolby is cheap for a reason, and the reason is legible in its own income statement. Revenue for the first six months of fiscal 2026 came to $742.3 million against $726.6 million a year earlier, a gain of roughly 2%. Operating profit over the same six months moved the other way, $175.1 million against $187.6 million, because total operating expenses climbed to $479.3 million from $462.3 million. A royalty business is supposed to be the shape where revenue growth outruns cost growth. Here it is the reverse, and it has been for long enough to show up in a half-year.
Underneath that sits the structural clock. The 10-K lists the ways patent protection fails and ends the list with "Patents eventually expire", and the company's own mitigation, replacing revenue from expiring patents with revenue from newer ones, describes a treadmill rather than an annuity. Every year the portfolio has to be rebuilt at the same size just to stand still, and the rebuilding is funded by the research and legal spending that is currently outgrowing revenue. That is the mechanism connecting the expense problem to the moat: the moat is the expense.
Revenue quality is thinner than the licensing label suggests. Very little of it is contracted forward, with $62.9 million of remaining performance obligations on the books as of March 27, 2026 against an annual revenue base above a billion dollars. Most royalties are estimated from licensee shipment reports and adjusted when the actual data arrives. And a recurring share comes from compliance work on shipments that were never properly declared, which the filing itself flags as "Recoveries are a recurring element of our business and are subject to fluctuation". Uneven and unpredictable revenue deserves a lower multiple than a subscription stream, which is part of why the stock carries the one it does.
Geography adds a second deterioration. International revenue for the first half of fiscal 2026 was $393.1 million, or 53% of the total, down from $424.1 million and 58% a year earlier. Roughly 63% of fiscal 2025 revenue came from outside the United States, so the larger half of the business is the half that shrank. Consumer electronics volume is where the royalty base lives, and it does not sit in North America.
Even priced for a slight decline, the price is not obviously supported. The asset-value methods leave the price about 80% above them and the earnings-power methods about 83% above, with peer multiples about 28% above. The cash-flow methods are the only ones that get anywhere near it. The reconciliation is which profit figure you believe: the earnings-power calculation capitalizes a normalized five-year average operating profit of about $250 million, while the trailing twelve months carried $330.5 million. If the five-year average is the honest read of a lumpy royalty stream, the multiple that looks like 12 is really something higher.
Stock compensation is the last drag, and it is not small. Against free cash flow of roughly 300 million dollars, stock compensation is running near 130 million a year, and capitalizing the net figure rather than the gross one lowers what that method supports by a wide margin. Unrecognized restricted-stock expense stood at $244.1 million as of March 27, 2026, to be recognized over about 2.8 years. The floor under all of this is genuine but modest. Outside the operating business the company carries roughly 81 million dollars of equity stakes in other entities, and it owes nothing to anyone. That bounds the downside without doing anything to fix the trend.
Valuation
Twelve times company-wide operating income is what the market will pay here, and inverted, that is not a growth assumption at all. It implies operating profit shrinking roughly 0.9% a year for five years. Keep the figures approximate: the calculation runs at an 8.9% cost of capital with 4% terminal growth, and one point of cost of capital moves the implied rate by about 5.5 points. Measured against the company's own record the pace is unremarkable. The price is simply not paying for the royalty base to compound.
Why that reads as a low bar comes down to the shape of the revenue. Licensing is 93.0% of it, and in fiscal 2025 that line produced $1,248.0 million of revenue against $83.6 million of direct cost. Products and services, the remaining 7.0%, generated $101.1 million of revenue against $76.5 million of cost, which is close to a break-even hardware business bolted onto a very profitable royalty stream. Trailing operating margin for the whole company is about 23.2%, and the distance between that figure and the underlying economics of the licensing line is entirely the corporate expense base.
The methods disagree in an unusual direction for a stock that screens inexpensively. The asset-value methods leave the price about 80% above them and the earnings-power methods about 83% above, with peer multiples about 28% above. Only the cash-flow methods reach the price, and the one that clears it does so on 4% growth in free cash flow and a 3.5% terminal rate, which is barely more than inflation. That the price still sits above nearly everything else, on those assumptions, is the finding. The reconciliation is which profit number is doing the work: the earnings-power calculation capitalizes a normalized five-year average operating profit of about $250 million, while the trailing twelve months carried $330.5 million.
The cohort reads the same way. This name sits in the lower half of its peer multiple range, which is where the market usually puts a licensor it does not expect to compound. IDCC turns a 49.6% operating margin on $828.9 million of revenue growing 1.6%, and RMBS turns 35.9% on $721.2 million growing 19.1%. Dolby's trailing operating margin of 23.2% is the lowest of the three on the largest revenue base, and closing that gap is what the rating would respond to.
Survival is not part of this discussion. There are no funded borrowings at all, and the company holds $594.7M in net cash. Interest expense is not separately reported in the filings, so coverage arithmetic is not the right lens here; the relevant fact is that nothing is owed. The share count has come down about 1.8% a year over the four years to March 27, 2026, the quarterly dividend was lifted to $0.36 from $0.33, and $141.6 million of repurchase authorization remained at the end of March. All of it is funded from operations, which is what lets a business priced for mild decline keep paying holders while it argues with that expectation.
Catalysts
Fiscal third-quarter results are due on July 30, 2026. Two things in that print matter more than the headline. The first is whether the expense line has started to bend: the restructuring begun in the second quarter is expected to deliver about 20 million dollars of gross pre-tax savings in operating income during fiscal 2026, and the first-half figures do not yet contain it. The second is the international line, which ran at $393.1 million for the first six months against $424.1 million a year earlier. That is where the royalty base is largest and where it has been contracting.
Away from the reported numbers, the adoption side keeps adding surfaces. Dolby was named a supplier of the year by General Motors for 2025, and Dolby Atmos has been integrated into the BMW 7 Series. Automotive works differently from consumer electronics: a design win locks the technology into a model cycle that runs for years, and the royalty then follows unit volume rather than an annual renegotiation. The same logic applies to streaming platform integrations, which put the technology in front of viewers on hardware the company never has to sell.
The capital-return schedule is the one predictable item. The quarterly dividend now stands at $0.36 a share, raised from $0.33, and $141.6 million of buyback authorization remained as of March 27, 2026. With no borrowings and $594.7M in net cash, none of that depends on the operating result. It means the July print is a read on the trend rather than on the company's ability to keep funding itself.
Peer Cohorts (Per Segment, With Filing Citations)
Audio/video technology licensing & products (single reportable segment) (reported)
- IDCC (INTERDIGITAL, INC.)
- FY2025 10-K: …advertisement-based video on demand ("AVOD") markets. Companies participating in these markets make, import, use or sell services making use of a number of video codecs and other technologies covered by our patent portfolio. In 2025, we initiated patent infringement actions involving major streaming ecosystem…
- FY2025 10-K: …range of consumer video entertainment platforms, including SVOD, AVOD, Virtual Multichannel Video Programming Distributor ("vMVPD"), Free Ad-Supported Streaming TV ("FAST"), and social media platforms. Collectively, the Video Services market is expected to grow from approximately $475 billion of annual revenue in…
- RMBS (RAMBUS INC)
- FY2025 10-K: …residual approach to estimate standalone selling prices primarily for service offerings sold to customers at highly variable pricing. Our revenue consists of product, royalties and contract and other revenue. Products primarily consist of memory interface chips sold directly and indirectly to module manufacturers and…
- FY2025 10-K: …and related disclosures. 4. Revenue Recognition Contract Balances The contract assets are primarily related to the Company's fixed fee IP licensing arrangements and rights to consideration for performance obligations delivered but not billed as of December 31, 2025. The Company's contract balances were as follows: As…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
company earnings calendar, report scheduled July 30, 2026 · company announcements, 2026